483
Teva Parenteral Medicines, Inc.FDA 483 - Teva Parenteral Medicines, Inc. - June 04, 2013
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Teva Parenteral Medicines Inc in Irvine, CA, from May 29 to June 4, 2013, revealed a significant failure to perform thorough investigations into unexplained discrepancies. The firm did not properly identify root causes for issues such as unmaintained equipment (a clean compressed air filter) and the use of a non-validated test method for endotoxin analysis, indicating deficiencies in their quality system and control unit oversight.
Open in Dashboard
ID · a341f217-c45e-4025-8a02-d53234f20847